Soros Fund Management’s MacroGenics MGNX Stock Holding History

Soros Fund Management’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-19,488	Closed	-$365K	–	215
2016 Q1	$365K	Hold	19,488	–	–	0.01%	184
2015 Q4	$604K	Hold	19,488	–	–	0.01%	178
2015 Q3	$417K	Hold	19,488	–	–	0.01%	210
2015 Q2	$740K	Hold	19,488	–	–	0.01%	218
2015 Q1	$611K	Hold	19,488	–	–	0.01%	212
2014 Q4	$683K	Hold	19,488	–	–	0.01%	180
2014 Q3	$407K	Hold	19,488	–	–	﹤0.01%	260
2014 Q2	$423K	Buy	+19,488	New	+$410K	﹤0.01%	287

Other funds holding MGNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BRC

Blue Ridge Capital New York $215M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Soros Fund Management's MGNX Position: Q2 2016 in Review

Soros Fund Management sold out of MacroGenics (MGNX) in Q2 2016, closing a stake of 19,488 shares — an estimated $365K sold.

Soros Fund Management first reported a position in MGNX in Q2 2014 and held it in 8 quarters. The position peaked at $740K in Q2 2015. 125 funds tracked by Wall St. Rank hold MGNX as of Q2 2016.

Soros Fund Management reported no remaining MacroGenics position as of Q2 2016 after selling out during the quarter.
Soros Fund Management sold 19,488 MacroGenics shares in Q2 2016, an estimated $365K.
Soros Fund Management first reported a position in MacroGenics in Q2 2014 and held it in 8 quarters.
Soros Fund Management's MacroGenics position peaked at $740K in Q2 2015.
125 funds tracked by Wall St. Rank held MacroGenics as of Q2 2016.

Based on Soros Fund Management's 13F filing for Q2 2016, filed 15 Aug 2016.